The Genetic Testing Landscape in Europe 2020
Theme: Treatment Priorities
Short-Term Evaluation of a Capacity Building Training Course (Retina International Education Hub) for Patients and Patient Representatives in Patient Involvement in Degenerative Retinal Diseases Research and Development
Artificial intelligence extension of the OSCAR-IB criteria
Fundamentals of the Diagnosis and Management of Inherited Retinal Diseases
Real-World Safety and Effectiveness of Voretigene Neparvovec: Results up to 2 Years from the Prospective, Registry-Based PERCEIVE Study
Lived experiences of genetic diagnosis for rare disease patients: a qualitative interview study
Post-Visual Diagnosis Distress: The Weight of Threatened Sight
A cost of illness model to estimate the annual societal costs of X-linked retinitis pigmentosa (XLRP) in the United Kingdom (UK)
The Landscape of Genomic Services for Inherited Retinal Degenerations (IRDs) Across Europe
Genetic Testing Experiences of People Living with Inherited Retinal Degenerations: Results of a Global Survey
Economic Burden of Late-Stage Age-Related Macular Degeneration in Bulgaria, Germany, and the US
Valuing patients’ high unmet need to drive innovative therapies for inherited retinal degenerations: insights from the RIWC 2024 workshop on value
-
close